An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Merck gets another quick return on its $3.9bn SpringWorks takeover with EU approval of Ezmekly for tumours caused by neurofibromatosis type 1.

Explore the latest pharmaceutical trends and predictions for 2025 from an incoming CEO's perspective. Stay ahead of the curve and prepare your organisation for the future.

Endo Pharmaceuticals has removed its Opana ER opioid painkiller from the US market at the request of the FDA.

The recent move to introduce an “Amazon-style” prescription tracking in the NHS App is a crucial first step. People want ...

Hemlibra (emicizumab), the only treatment currently available for haemophilia A via the NHS that doesn't require an ...

In a new study, the large-language model (LLM) ChatGPT was able to reduce the time needed to review whether a patient is suitable for a clinical trial and delivered big reductions – from an average of ...

From trade associations to medtech innovators and biotech start-ups, here’s a comprehensive look at the latest boardroom ...

"For decades, bureaucrats and entrenched interests buried health data and blocked patients from taking control of their ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie.

Robin Walsh takes a look back at the origins of the industry in the 19th century and its ongoing evolution ...

In the next part of his series on the history of the pharmaceutical industry, Robin Walsh looks at the biggest company of them all – Pfizer. Pfizer was founded in 1849 by two recent German ...